Natural Orifice Transluminal Endoscopic Surgery for Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: natural orifice specimen extractionProcedure: Laparoendoscopic resection
- Registration Number
- NCT02549456
- Lead Sponsor
- Mansoura University
- Brief Summary
The purpose of this study is to assess different hybrid natural orifice transluminal endoscopic surgery techniques in management of colorectal cancer as regard: feasibility of the technique, short term oncologic outcome and functional outcome.
- Detailed Description
Intervention will be done by conventional laparoscopy and transanal endoscopy (TEO or Gelpoint platform), patients are divided into two arms to compare different natural orifice techniques in resection of colorectal cancer.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Medically fit patient.
- Non metastatic pathologically proven sigmoid colon cancer.
- Non metastatic pathologically proven rectal cancer.
- Patient continent for stool.
- Patients with American Society of Anesthesiologist (ASA) score 4 and 5.
- Patients with cardiac or chest problems that cannot withstand insufflation.
- Unresectable tumors (defined as those who cannot be resected without a high likelihood of leaving microscopic or gross residual disease at the local site because of tumor adherence or fixation).
- Obstructed or perforated cancer.
- Patients with metastatic colorectal cancer.
- Incontinent patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Natural orifice specimen extraction natural orifice specimen extraction Conventional laparoscopic resection of colorectal cancer with natural orifice specimen extraction Laparoendoscopic resection Laparoendoscopic resection Laparoscopic assisted transanal endoscopic resection of rectal cancer
- Primary Outcome Measures
Name Time Method Major postoperative complications two weeks leak-bleeding
Feasibility 24 hour Rate of conversion to classic laparoscopy or to open laparotomy.
Operative blood loss 24 hour measured in milliliter
Wound complications two week infection-dehiscence
operative time 24 hour time taken from starting operation till patient wake up
Major intraoperative complications 24 hour bleeding -organ injury
- Secondary Outcome Measures
Name Time Method Longitudinal safety margin one month either free or infiltrated with tumor by histopathology examination.
Grading of quality and completeness of mesorectal excision one month It is a composite outcome where result will appear as either complete, near complete or incomplete. Criteria in (shape, coning, presence of defects and circumferential safety margin) will be integrated to categorize it.
short term oncologic outcome 6 months - one year incidence of local and distant outcomes and disease free survival
Functional outcome 3 months assessing fecal incontinence using Kirwan's grading score
Adequacy of lymphadenectomy one month Number of lymph nodes retrieved
Trial Locations
- Locations (1)
Oncology center Mansoura University
🇪🇬Mansoura, Dakahlia, Egypt